Brought to you by:
Explaining the No Surprises Act
The vast scope of the No Surprises Act—legislation signed into law in late 2020—may mean some Society for Vascular Surgery (SVS) members are not aware of its provisions. The No Surprises Act is part of the Consolidation Appropriateness Act of…
‘Leveraging multiple teams and cardiovascular specialists’
This quarter’s Leadership Corner features Young Erben, MD, interviewing Charles B. Ross, MD, chief of vascular and endovascular services at Piedmont Heart Institute, Piedmont Hospital, Atlanta, since 2012. I am highlighting the innovative work of Dr. Ross, current medical leader…
TCAR affords greater quality-adjusted life years than carotid endarterectomy, cost-effectiveness model finds
A cost-effectiveness model based on peer-reviewed sources suggests that although five-year costs for transcarotid artery revascularization (TCAR) were higher than those for carotid endarterectomy (CEA), TCAR afforded greater quality-adjusted life years (QALY). The study was published in the December 2021 issue of the…
SVS issues new guidelines covering carotid disease and popliteal aneurysms
The Society for Vascular Surgery (SVS) has released updated clinical practice guidelines for the management of extracranial cerebrovascular disease and popliteal artery aneurysms in a special supplement, “The Care of Patients with Extracranial Cerebrovascular Disease and Popliteal Artery Aneurysms: The…
Task Force to address question: How will we care for pediatric vascular patients?
Along with the American Pediatric Surgical Association (APSA), the Society for Vascular Surgery (SVS) plans to minimize and close some very real gaps in vascular care—treating pediatric patients. The two organizations have formed a joint task force on the issue…
In paying back, Joe Hart pays it forward
For Joe Hart, MD, a larger donation to the Society for Vascular Surgery (SVS) Foundation this past year is helping him pay back several of his own scholarships and research opportunities from which he benefited. “I’m someone who’s been fortunate…
Wei Zhou: Prepared for change—and a more diverse, vocal generation of surgeons
There was something of a different pulse to some of the matters around this year’s Western Vascular Society (WVS) annual meeting, recalls Wei Zhou, MD, a regular attendee over the last decade—particularly during a session dedicated to issues related to…
Venous disease: SVS DEI Committee seeks survey participants
The Society for Vascular Surgery (SVS) Diversity, Equity and Inclusion (DEI) Committee is calling on vascular surgeons to complete a survey focused on patterns of practice in venous disease. Responses are due by Friday, Dec. 31. The committee seeks respondents…
Planning underway for next VAM
One of the innovations—livestreaming— introduced at the 2021 Vascular Annual Meeting (VAM), is influencing the 2022 schedule. “The streaming option, particularly for international members, was a big hit,” said Andres Schanzer, MD, chair of the Society for Vascular Surgery (SVS)…
Collaborative effort key to investigating potential biomarker of acute aortic syndrome
Research indicates that plasma desmosine has the potential to act as a biomarker of acute aortic syndrome and could, in the future, be used as a diagnostic tool for the condition in the acute setting. Presenting the findings of a British Heart…